S&P 500   4,263.75 (+0.81%)
DOW   33,129.55 (+0.39%)
QQQ   359.75 (+1.36%)
AAPL   173.66 (+0.73%)
MSFT   318.95 (+1.77%)
META   305.58 (+1.54%)
GOOGL   135.24 (+2.12%)
AMZN   127.00 (+1.83%)
TSLA   261.16 (+5.93%)
NVDA   440.41 (+1.20%)
NIO   8.83 (+2.56%)
BABA   84.08 (-0.54%)
AMD   104.07 (+3.99%)
T   14.65 (-0.88%)
F   11.99 (-0.66%)
MU   68.11 (+0.41%)
CGC   0.75 (+10.19%)
GE   108.85 (+1.01%)
DIS   79.32 (-0.28%)
AMC   8.34 (+6.24%)
PFE   33.31 (-1.74%)
PYPL   58.57 (+2.22%)
NFLX   376.90 (+0.04%)
S&P 500   4,263.75 (+0.81%)
DOW   33,129.55 (+0.39%)
QQQ   359.75 (+1.36%)
AAPL   173.66 (+0.73%)
MSFT   318.95 (+1.77%)
META   305.58 (+1.54%)
GOOGL   135.24 (+2.12%)
AMZN   127.00 (+1.83%)
TSLA   261.16 (+5.93%)
NVDA   440.41 (+1.20%)
NIO   8.83 (+2.56%)
BABA   84.08 (-0.54%)
AMD   104.07 (+3.99%)
T   14.65 (-0.88%)
F   11.99 (-0.66%)
MU   68.11 (+0.41%)
CGC   0.75 (+10.19%)
GE   108.85 (+1.01%)
DIS   79.32 (-0.28%)
AMC   8.34 (+6.24%)
PFE   33.31 (-1.74%)
PYPL   58.57 (+2.22%)
NFLX   376.90 (+0.04%)
S&P 500   4,263.75 (+0.81%)
DOW   33,129.55 (+0.39%)
QQQ   359.75 (+1.36%)
AAPL   173.66 (+0.73%)
MSFT   318.95 (+1.77%)
META   305.58 (+1.54%)
GOOGL   135.24 (+2.12%)
AMZN   127.00 (+1.83%)
TSLA   261.16 (+5.93%)
NVDA   440.41 (+1.20%)
NIO   8.83 (+2.56%)
BABA   84.08 (-0.54%)
AMD   104.07 (+3.99%)
T   14.65 (-0.88%)
F   11.99 (-0.66%)
MU   68.11 (+0.41%)
CGC   0.75 (+10.19%)
GE   108.85 (+1.01%)
DIS   79.32 (-0.28%)
AMC   8.34 (+6.24%)
PFE   33.31 (-1.74%)
PYPL   58.57 (+2.22%)
NFLX   376.90 (+0.04%)
S&P 500   4,263.75 (+0.81%)
DOW   33,129.55 (+0.39%)
QQQ   359.75 (+1.36%)
AAPL   173.66 (+0.73%)
MSFT   318.95 (+1.77%)
META   305.58 (+1.54%)
GOOGL   135.24 (+2.12%)
AMZN   127.00 (+1.83%)
TSLA   261.16 (+5.93%)
NVDA   440.41 (+1.20%)
NIO   8.83 (+2.56%)
BABA   84.08 (-0.54%)
AMD   104.07 (+3.99%)
T   14.65 (-0.88%)
F   11.99 (-0.66%)
MU   68.11 (+0.41%)
CGC   0.75 (+10.19%)
GE   108.85 (+1.01%)
DIS   79.32 (-0.28%)
AMC   8.34 (+6.24%)
PFE   33.31 (-1.74%)
PYPL   58.57 (+2.22%)
NFLX   376.90 (+0.04%)
NASDAQ:ETON

Eton Pharmaceuticals (ETON) Earnings Date, Estimates & Call Transcripts

$4.04
+0.13 (+3.32%)
(As of 04:00 PM ET)
Compare
Today's Range
$3.90
▼
$4.10
50-Day Range
$2.55
▼
$5.63
52-Week Range
$1.98
▼
$5.81
Volume
93,190 shs
Average Volume
193,260 shs
Market Capitalization
$103.63 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.00
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
Nov. 9Estimated
Actual EPS
(Aug. 10)
$0.18 Beat By $0.27
Consensus EPS
(Aug. 10)
-$0.09
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

ETON Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ETON Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Eton Pharmaceuticals Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20231($0.14)($0.14)($0.14)
Q2 20231($0.12)($0.12)($0.12)
Q3 20231($0.05)($0.05)($0.05)
Q4 20231($0.04)($0.04)($0.04)
FY 20234($0.35)($0.35)($0.35)
Q1 20241($0.03)($0.03)($0.03)
Q2 20241$0.02$0.02$0.02
Q3 20241$0.03$0.03$0.03
Q4 20241$0.06$0.06$0.06
FY 20244$0.08$0.08$0.08

ETON Earnings Date and Information

Eton Pharmaceuticals last issued its earnings data on August 10th, 2023. The reported $0.18 earnings per share for the quarter, topping analysts' consensus estimates of ($0.09) by $0.27. The firm had revenue of $12 million for the quarter, compared to analyst estimates of $6.50 million. Eton Pharmaceuticals has generated $0.00 earnings per share over the last year. Earnings for Eton Pharmaceuticals are expected to grow in the coming year, from ($0.10) to $0.26 per share. Eton Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 9th, 2023 based off prior year's report dates.

Eton Pharmaceuticals Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/9/2023
Estimated)		------- 
8/10/2023Q2 2023($0.09)$0.18+$0.27$0.18$6.50 million$12.00 million
5/11/2023Q1 2023($0.14)($0.10)+$0.04($0.10)$4.60 million$5.30 million
3/16/2023Q4 2022$0.01$0.04+$0.03$0.04$9.10 million$8.50 million
11/10/2022Q3 2022($0.15)($0.12)+$0.03($0.12)$3.00 million$3.22 million
8/11/2022Q2 2022$0.03($0.06)($0.09)($0.06)$7.77 million$7.36 million
5/12/2022Q1 2022($0.08)($0.21)($0.13)($0.21)$7.07 million$2.18 million
3/16/2022Q4 2021$0.05$0.04($0.01)$0.04$7.56 million$6.09 million    
11/15/2021Q3 2021($0.14)($0.24)($0.10)($0.24)$3.05 million$0.78 million    
8/15/2021Q2 2021($0.14)($0.10)+$0.04($0.08)$3.83 million$3.07 million    
5/13/2021Q1 2021$0.19$0.19-$0.19$12.05 million$11.90 million  
3/15/2021Q4 2020($0.26)($0.32)($0.06)($0.32)$1.04 million$0.08 million  
11/12/2020Q3 2020($0.26)($0.31)($0.05)($0.31)$1.49 million($0.16) million  












Eton Pharmaceuticals Earnings - Frequently Asked Questions

When is Eton Pharmaceuticals's earnings date?

Eton Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 9th, 2023 based off last year's report dates. Learn more on ETON's earnings history.

Did Eton Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, Eton Pharmaceuticals (NASDAQ:ETON) reported $0.18 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.09) by $0.27. Learn more on analysts' earnings estimate vs. ETON's actual earnings.

How much revenue does Eton Pharmaceuticals generate each year?

Eton Pharmaceuticals (NASDAQ:ETON) has a recorded annual revenue of $21.25 million.

How much profit does Eton Pharmaceuticals generate each year?

Eton Pharmaceuticals (NASDAQ:ETON) has a recorded net income of -$9.02 million. ETON has generated $0.00 earnings per share over the last four quarters.

What is Eton Pharmaceuticals's EPS forecast for next year?

Eton Pharmaceuticals's earnings are expected to grow from ($0.10) per share to $0.26 per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:ETON) was last updated on 10/4/2023 by MarketBeat.com Staff

My Account -